-
Can AI Make Israel the World’s Next Biotech Superpower?
09 Jul 2025 20:28 GMT
… with AI-driven biotech innovation aimed at revolutionizing drug development Just weeks … target combinations for multispecific biologic drugs—treatments designed to act … complicated than developing single-target drugs.
Traditional discovery methods rely …
-
Biotech Hits Record High On 'Impressive' Results In Obesity Treatment
09 Jul 2025 23:49 GMT
… in a public offering.
The biotech company is hoping to treat …
NOW PLAYING
The Weight-Loss Drug Market Is Hot. Which Medical … shows up with Imcivree, another drug from Rhythm that treats other … and Rhythm's new drug, bivamelagon, impact a receptor called …
-
More Chinese ADCs enter the clinic as biotech race heats up
09 Jul 2025 23:35 GMT
China has proved to be a fertile ground for innovation as evidenced by some big deals in the antibody-drug conjugate (ADC) space, and the number of candidates entering clinical trials in China or being advanced in the U.S. by Chinese companies.
BioWorld …
-
JACKSON HEWETT: Australia’s biotech industry pops chill pill following Trump tariff scare
09 Jul 2025 22:55 GMT
… and pharmaceutical ingredients, including finished drug products, medical countermeasures, critical … export in Australia.
“Australian biotechnology and medical technology companies compete … device companies rather than drug manufacturers.
Other companies were …
-
Merck to buy Verona and its lung drug in $10B deal
09 Jul 2025 20:27 GMT
… potential multibillion-dollar new drug to treat chronic obstructive … Wednesday.
The Food and Drug Administration approved Verona’s … investors, Merck said the drug strengthens its growing cardio- … -biggest acquisition of a biotechnology company this year, after …
-
Spartan Capital Securities, LLC Serves as Placement Agent in Lixte Biotechnology Holdings, Inc.’s $1.5 Million Registered Direct Offering
09 Jul 2025 21:15 GMT
… registered direct offering for Lixte Biotechnology Holdings, Inc. (NASDAQ: LIXT … Biotechnology Holdings, Inc., a clinical-stage pharmaceutical company focused on cancer drug … .com. About Lixte Biotechnology Holdings, Inc.
Lixte Biotechnology Holdings, Inc. is …
-
Biotech firm Verona snapped up by Merck in $10bn deal
09 Jul 2025 19:33 GMT
A London-based biotech company created by British … , a respiratory drugs company with a potential blockbuster drug, comes five … from Aim in 2020.
The drug, Ohtuvayre, a potential blockbuster, … it’s a bi-functional drug.”
David Zaccardelli, chief executive …
-
Factbox-Major deals involving U.S. drugmakers and biotechs over the past decade
09 Jul 2025 17:58 GMT
… worth of pharmaceuticals and biotech M&A deals … 11.5 popular billion obesity drug (excluding Wegovy debt) 2023 … on rare-disease and immunology drugs 2020 Bristol MyoKardia About … billion acquires blockbuster prostate cancer drug Xtandi 2015 Shire Baxalta …
-
Merck nears $10 billion deal for biotech Verona
09 Jul 2025 17:56 GMT
… leaned on its blockbuster cancer drug Keytruda, which generated nearly … talks to buy Swiss biotech MoonLake Immunotherapeutics for more … for a heart disease drug with Jiangsu Hengrui Pharmaceuticals. … international launch of the drug in countries outside the …
-
Stocks Shrug Off Trump's Threat To Slam Drugs With Tariffs
09 Jul 2025 14:55 GMT
… the airways.
↑
X
NOW PLAYING
Biotech';s Next Boom? Inside … .71.
Verona's drug works differently from Regeneron Pharmaceuticals… . Dupixent is an injected drug that blocks an inflammatory cytokine … To 200% Tariffs On Drug Imports. The Market Doesn…